Non Hodgkin's Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
2021-11-15
Nov 15, 2021
B
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
Active, not recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +2 more
  • CD19CAR/virus specific T cells
  • Benadryl and Tylenol
  • Houston, Texas
  • +1 more
2021-08-31
Aug 31, 2021
G
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - 2017
Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
2021-08-12
Aug 12, 2021
W
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies
Recruiting
  • Acute Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
2021-04-05
Apr 5, 2021
C
Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma
Recruiting
  • Non Hodgkin's Lymphoma
  • Shijiazhuang, Hebei, China
    The fourth hospital of Hebei Medical University
2020-08-02
Aug 2, 2020
A
Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn
Withdrawn
  • Non Hodgkin's Lymphoma
  • (no location specified)
2020-01-21
Jan 21, 2020
N
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies - 2015
Completed
  • Hodgkin Lymphoma
  • +8 more
  • Stem cell transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2019-12-13
Dec 13, 2019
M
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States - 2004
Terminated
  • Leukemia
  • +2 more
  • Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation
  • Houston, Texas
    MD Anderson Cancer Center
2018-10-29
Oct 29, 2018
S
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide - 2018
Completed
  • Hodgkin's Lymphoma
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2018-10-12
Oct 12, 2018
F
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) - 2018
Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • +4 more
  • Eltrombopag Olamine
  • Vicenza, Italy
    Department of Hematology, Ospedale San Bortolo
2018-07-12
Jul 12, 2018
N
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants - 2015
Completed
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Th2 cells in allo HSCTT
  • Th2 Cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2018-07-03
Jul 3, 2018
M
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant - 2012
Terminated
  • Non Hodgkin's Lymphoma
  • +2 more
  • Fludarabine and total body irradiation
  • Total body irradiation
  • Boston, Massachusetts
    Massachusetts General Hospital
2018-03-26
Mar 26, 2018
U
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies - 2013
Terminated
Has Results
  • Multiple Myeloma
  • +4 more
  • Birmingham, Alabama
    University of Alabama in Birmingham BMT/CT Program Outpatient Cl
2017-06-22
Jun 22, 2017
S
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies - 2012
Completed
  • Acute Myeloid Leukemia
  • +6 more
  • infusion of allogeneic CIK cells
  • Singapore, Singapore
    Singapore General Hospital
2017-02-09
Feb 9, 2017
D
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant - 2016
Completed
  • Hodgkin's Disease
  • +4 more
    • Durham, North Carolina
      Duke University Health System
    2016-05-03
    May 3, 2016
    M
    Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma - 2008
    Completed
    • Tumors
    • Non Hodgkin's Lymphoma
    • Baltimore, Maryland
    • +2 more
    2015-01-06
    Jan 6, 2015
    I
    Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL - 2010
    Completed
    • Non Hodgkin's Lymphoma
    • Indianapolis, Indiana
      Indiana University Cancer Center
    2014-09-10
    Sep 10, 2014
    D
    Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant - 2013
    Completed
    Has Results
    • Hodgkin's Disease
    • +4 more
    • Non-myeloablative Stem Cell Transplantation
    • Durham, North Carolina
      Duke University Health System
    2014-05-02
    May 2, 2014
    U
    Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
    Unknown status
    • Acute Myeloid Leukemia
    • +7 more
    • allogeneic donor derived B-lymphocytes
    • Erlangen, Germany
      Medical Department 5, University Hospital Erlangen
    2014-03-24
    Mar 24, 2014
    G
    Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). - 2009
    Completed
    • Lymphoma
    • +3 more
    • Plerixafor (AMD3100)
    • Can be any registered nonpegylated form of G-CSF
    • Berlin, Germany
    • +4 more
    2014-02-10
    Feb 10, 2014
    T
    Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B - 2012
    Completed
    • Non Hodgkin's Lymphoma
    • Hepatitis B
    • Entecavir prophylaxis
    • Therapeutic entecavir
    • Taipei, Taiwan
      Taipei Veterans General Hospital-Division of Gastroenterology, D
    2013-05-27
    May 27, 2013
    U
    Positron Emission Tomography(PET) in Lymphoma Assessment - 2011
    Completed
    • Hodgkin's Lymphoma
    • Non Hodgkin's Lymphoma
    • PET Scan
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    2012-12-17
    Dec 17, 2012
    M
    CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation - 2002
    Terminated
    • Chronic Myelogenous Leukemia
    • +4 more
    • CD8 Depleted Donor Lymphocyte
    • Houston, Texas
      UT MD Anderson Cancer Center
    2012-08-22
    Aug 22, 2012
    F
    Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL - 2011
    Completed
    • Lymphoma
    • Non Hodgkin's Lymphoma
    • Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
    • San Juan, Puerto Rico
      Hospital Auxilio Mutuo Cancer Center
    2012-02-03
    Feb 3, 2012
    I
    BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)
    Unknown status
    • Non Hodgkin's Lymphoma
    • Busulfan, Etoposide, Cytarabine, Melphalan
    • Busan, Korea, Republic of
    • +4 more
    2010-12-01
    Dec 1, 2010